Clinical Trial Update: Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 open-label study evaluating the safety and efficacy of AK101 injections for plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AK101

Snippet

Sponsor: Akeso | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED